BG107046A - Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans - Google Patents
Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofuransInfo
- Publication number
- BG107046A BG107046A BG107046A BG10704602A BG107046A BG 107046 A BG107046 A BG 107046A BG 107046 A BG107046 A BG 107046A BG 10704602 A BG10704602 A BG 10704602A BG 107046 A BG107046 A BG 107046A
- Authority
- BG
- Bulgaria
- Prior art keywords
- dihydroisobenzofurans
- fluorophenyl
- substituted
- stepwise alkylation
- alkylation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D277/10—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200000403 | 2000-03-13 | ||
| DKPA200000414 | 2000-03-14 | ||
| PCT/DK2001/000159 WO2001068629A1 (en) | 2000-03-13 | 2001-03-09 | Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG107046A true BG107046A (en) | 2003-05-30 |
Family
ID=26068792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG107046A BG107046A (en) | 2000-03-13 | 2002-09-02 | Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6864379B2 (xx) |
| EP (1) | EP1265881A1 (xx) |
| JP (1) | JP2003527385A (xx) |
| KR (1) | KR20020080485A (xx) |
| CN (1) | CN1427835A (xx) |
| AU (1) | AU2001239210A1 (xx) |
| BG (1) | BG107046A (xx) |
| BR (1) | BR0109364A (xx) |
| CA (1) | CA2402553A1 (xx) |
| CZ (1) | CZ20023100A3 (xx) |
| EA (1) | EA200200968A1 (xx) |
| HR (1) | HRP20020758A2 (xx) |
| HU (1) | HUP0300273A2 (xx) |
| IL (1) | IL151566A0 (xx) |
| IS (1) | IS6530A (xx) |
| MX (1) | MXPA02008684A (xx) |
| NO (1) | NO20024352L (xx) |
| NZ (1) | NZ521204A (xx) |
| PL (1) | PL357022A1 (xx) |
| SK (1) | SK14522002A3 (xx) |
| TR (1) | TR200202195T2 (xx) |
| WO (1) | WO2001068629A1 (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA004033B1 (ru) | 1999-04-14 | 2003-12-25 | Х.Лундбекк А/С | Способ получения циталопрама |
| IES20010157A2 (en) | 2000-03-03 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| IES20010206A2 (en) | 2000-03-13 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| AR032455A1 (es) | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
| BR0213949A (pt) * | 2001-11-08 | 2004-08-31 | Sepracor Inc | Métodos para o tratamento de depressão e outros distúrbios do snc utilizando metabólitos desmetila e didesmetila de citalopram enanciomericamente enriquecidos |
| US7078541B2 (en) * | 2002-02-07 | 2006-07-18 | Galileo Pharmaceuticals, Inc. | Benzofuran derivatives |
| PE20040991A1 (es) | 2002-08-12 | 2004-12-27 | Lundbeck & Co As H | Separacion de intermediarios para la preparacion de escitalopram |
| AU2003223105A1 (en) * | 2003-03-24 | 2004-10-18 | Hetero Drugs Limited | Novel crystalline forms of (s)-citalopram oxalate |
| WO2005047274A1 (en) * | 2003-11-12 | 2005-05-26 | Dr. Reddy's Laboratories, Inc. | Preparation of escitalopram |
| TWI339651B (en) | 2004-02-12 | 2011-04-01 | Lundbeck & Co As H | Method for the separation of intermediates which may be used for the preparation of escitalopram |
| EP2322940B1 (en) * | 2005-03-10 | 2014-10-29 | Gen-Probe Incorporated | Systems amd methods to perform assays for detecting or quantifing analytes within samples |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1143702A (xx) | 1965-03-18 | |||
| GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
| GB8419963D0 (en) | 1984-08-06 | 1984-09-12 | Lundbeck & Co As H | Intermediate compound and method |
| GB8814057D0 (en) | 1988-06-14 | 1988-07-20 | Lundbeck & Co As H | New enantiomers & their isolation |
| US5296507A (en) | 1990-09-06 | 1994-03-22 | H.Lundbeck A/S | Treatment of cerbrovascular disorders |
| DE19626659A1 (de) | 1996-07-03 | 1998-01-08 | Basf Ag | Verfahren zur Herstellung von Phthaliden |
| DE19627697A1 (de) | 1996-07-10 | 1998-01-15 | Basf Ag | Verfahren zur Herstellung von Phthaliden |
| DE69801764T2 (de) | 1997-07-08 | 2002-07-04 | Lundbeck & Co As H | Verfahren zur herstellung von citalopram |
| UA62985C2 (en) | 1997-11-10 | 2004-01-15 | Lunnbeck As H | A method for the preparation of citalopram |
| DE69714480T2 (de) | 1997-11-11 | 2003-03-06 | Lundbeck & Co As H | Verfahren zur Herstellung von Citalopram |
| PL199423B1 (pl) | 1998-10-20 | 2008-09-30 | Lundbeck & Co As H | Sposób wytwarzania citalopramu |
| JP2002533450A (ja) | 1998-12-23 | 2002-10-08 | ハー・ルンドベック・アクチエゼルスカベット | ５−シアノフタリドの製造方法 |
| AR022329A1 (es) | 1999-01-29 | 2002-09-04 | Lundbeck & Co As H | Metodo para la preparacion de 5-cianoftalida |
| EA004033B1 (ru) | 1999-04-14 | 2003-12-25 | Х.Лундбекк А/С | Способ получения циталопрама |
| ITMI991579A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| ITMI991581A1 (it) | 1999-06-25 | 2001-01-15 | Lundbeck & Co As H | Metodo per la preparazione di citalopram |
| ES2229774T3 (es) | 1999-10-25 | 2005-04-16 | H. Lundbeck A/S | Metodo para la preparacion de citalopram. |
| US6310222B1 (en) | 1999-11-01 | 2001-10-30 | Sumika Fine Chemicals Co., Ltd. | Production method of 5-phthalancarbonitrile compound, intermediate therefor and production method of the intermediate |
| AR026063A1 (es) | 1999-11-01 | 2002-12-26 | Lundbeck & Co As H | Metodo para la preparacion de 5-carboxiftalida. |
| ES2219095T3 (es) | 1999-12-28 | 2004-11-16 | H. Lundbeck A/S | Metodo para la preparacion de citalopram. |
| UA73336C2 (en) | 1999-12-30 | 2005-07-15 | Lundbeck & Co As H | A method for the preparation of 5-cyano-phtalid |
| ES2206177T3 (es) | 2000-01-14 | 2004-05-16 | H. Lundbeck A/S | Metodo para la preparacion de 5-cianoftalida. |
| IT1317729B1 (it) | 2000-01-18 | 2003-07-15 | Norpharma S P A | Procedimento per la preparazione della 5-carbossiftalide. |
| US6433196B1 (en) | 2000-02-17 | 2002-08-13 | Sumika Fine Chemicals Co., Ltd. | Production method of citalopram, intermediate therefor and production method of the intermediate |
| FR2805812A1 (fr) | 2000-02-24 | 2001-09-07 | Lundbeck & Co As H | Procede de preparation du citalopram |
| IES20010143A2 (en) | 2000-02-24 | 2001-07-25 | Lundbeck & Co As H | Method for the preparation of citalopram |
| IES20010157A2 (en) * | 2000-03-03 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| GB0005477D0 (en) | 2000-03-07 | 2000-04-26 | Resolution Chemicals Limited | Process for the preparation of citalopram |
| EP1265883A1 (en) | 2000-03-13 | 2002-12-18 | H. Lundbeck A/S | Method for the preparation of citalopram |
| IES20010206A2 (en) | 2000-03-13 | 2002-03-06 | Lundbeck & Co As H | Method for the preparation of citalopram |
| DE60101786T2 (de) | 2000-03-14 | 2004-07-15 | H. Lundbeck A/S, Valby | Verfahren zur herstellung von citalopram |
| AU2001244086A1 (en) | 2000-03-16 | 2001-09-24 | H. Lundbeck A/S | Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| AR032455A1 (es) | 2000-05-12 | 2003-11-12 | Lundbeck & Co As H | Metodo para la preparacion de citalopram, un intermediario empleado en el metodo, un metodo para la preparacion del intermediario empleado en el metodo y composicion farmaceutica antidepresiva |
| AU2001272368A1 (en) | 2000-07-06 | 2002-01-21 | H. Lundbeck, A/S | Method for the preparation of citalopram |
| FI20011622A (fi) | 2000-08-18 | 2002-02-19 | Lundbeck & Co As H | Menetelmä sitalopraamin valmistamiseksi |
| TR200201166T1 (tr) | 2000-12-22 | 2002-10-21 | H.Lundbecks A/S | Saf sitalopram hazırlanması için yöntem |
| TR200200018T1 (tr) | 2000-12-28 | 2002-06-21 | H. Lundbeck A/S | Saf sitalopram hazırlanması için yöntem. |
-
2001
- 2001-03-09 CZ CZ20023100A patent/CZ20023100A3/cs unknown
- 2001-03-09 CN CN01809125A patent/CN1427835A/zh active Pending
- 2001-03-09 NZ NZ521204A patent/NZ521204A/en unknown
- 2001-03-09 WO PCT/DK2001/000159 patent/WO2001068629A1/en not_active Application Discontinuation
- 2001-03-09 BR BR0109364-9A patent/BR0109364A/pt not_active IP Right Cessation
- 2001-03-09 JP JP2001567721A patent/JP2003527385A/ja not_active Withdrawn
- 2001-03-09 KR KR1020027012044A patent/KR20020080485A/ko not_active Application Discontinuation
- 2001-03-09 SK SK1452-2002A patent/SK14522002A3/sk unknown
- 2001-03-09 EP EP01913735A patent/EP1265881A1/en not_active Withdrawn
- 2001-03-09 CA CA002402553A patent/CA2402553A1/en not_active Abandoned
- 2001-03-09 HU HU0300273A patent/HUP0300273A2/hu unknown
- 2001-03-09 MX MXPA02008684A patent/MXPA02008684A/es unknown
- 2001-03-09 PL PL01357022A patent/PL357022A1/xx not_active Application Discontinuation
- 2001-03-09 AU AU2001239210A patent/AU2001239210A1/en not_active Abandoned
- 2001-03-09 IL IL15156601A patent/IL151566A0/xx unknown
- 2001-03-09 TR TR2002/02195T patent/TR200202195T2/xx unknown
- 2001-03-09 EA EA200200968A patent/EA200200968A1/ru unknown
-
2002
- 2002-08-27 IS IS6530A patent/IS6530A/is unknown
- 2002-09-02 BG BG107046A patent/BG107046A/xx unknown
- 2002-09-10 US US10/242,804 patent/US6864379B2/en not_active Expired - Fee Related
- 2002-09-12 NO NO20024352A patent/NO20024352L/no not_active Application Discontinuation
- 2002-09-18 HR HRP20020758 patent/HRP20020758A2/hr not_active Application Discontinuation
-
2004
- 2004-08-13 US US10/917,667 patent/US20050020670A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20020080485A (ko) | 2002-10-23 |
| IS6530A (is) | 2002-08-27 |
| IL151566A0 (en) | 2003-04-10 |
| AU2001239210A1 (en) | 2001-09-24 |
| NO20024352D0 (no) | 2002-09-12 |
| BR0109364A (pt) | 2002-12-24 |
| CN1427835A (zh) | 2003-07-02 |
| NZ521204A (en) | 2004-03-26 |
| HUP0300273A2 (hu) | 2003-06-28 |
| CA2402553A1 (en) | 2001-09-20 |
| TR200202195T2 (tr) | 2002-12-23 |
| CZ20023100A3 (cs) | 2003-02-12 |
| US6864379B2 (en) | 2005-03-08 |
| NO20024352L (no) | 2002-10-08 |
| HRP20020758A2 (en) | 2004-12-31 |
| US20030083509A1 (en) | 2003-05-01 |
| SK14522002A3 (sk) | 2003-03-04 |
| WO2001068629A1 (en) | 2001-09-20 |
| EA200200968A1 (ru) | 2003-02-27 |
| PL357022A1 (en) | 2004-07-12 |
| US20050020670A1 (en) | 2005-01-27 |
| EP1265881A1 (en) | 2002-12-18 |
| JP2003527385A (ja) | 2003-09-16 |
| MXPA02008684A (es) | 2003-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001079460A3 (en) | Polypeptides having haloperoxidase activity | |
| MY136969A (en) | Mpeg table structure | |
| BR9915534B1 (pt) | 1-piridil substituìdo)-1,2,4-triazóis inseticidas. | |
| MY139523A (en) | Ziprasidone composition and synthetic controls | |
| UY26451A1 (es) | Procedimiento para la obtención de 1,2,3,4- tetrahidroquinolinas 4-carboxiamino-2-sustituidas | |
| MXPA04004939A (es) | 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3-alquilados y 5,5??,6,6??,7,7??,8,8??-octahidro-2,2??-binaftoles 3,3??-dialquilados y procesos para su fabricacion. | |
| HK1069171A1 (en) | Substituted 6H-dibenzioÄc,hÜchromenes as estrogenic agents. | |
| EP1172112B8 (en) | Preventive, alleviative or remedy for hypertension | |
| BG107049A (en) | Method for the preparation of 5-cyano-1-(4-fluorophenyl)-1,3-dihydroisobenzofurans | |
| BG107046A (en) | Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans | |
| BG107047A (en) | Method for the preparation of citalopram | |
| MY141607A (en) | Lactam compound | |
| HK1052512A1 (en) | Method for the preparation of citalopram | |
| HK1042484A1 (en) | Processes for the preparation of (r)-a-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)-4-piperidinemethanol | |
| MXPA02004860A (es) | 3-(4,5-dihdroisoxazol-5-il) benzoilpirazoles. | |
| MXPA03002926A (es) | Proceso para la sintesis de 2,2,6,6,-tetrametil-4--oxipiperidina. | |
| ID27733A (id) | Metoksiminofenilasetamida | |
| IT1320082B1 (it) | Procedimento per la realizzazione di reggiseni, nonche' reggisenocosi' ottenuto. | |
| GB2385051B (en) | Improved process for the preparation of 5-substituted-1 (4-fluorophenyl)-1,3-dihydro isobenzofurans | |
| BG102613A (en) | New substituted imidazoles | |
| AR027974A1 (es) | 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas | |
| MXPA03006932A (es) | Derivado de indolina y procedimiento para la produccion del mismo. | |
| BG102318A (en) | Epoxy-azetidinons, their preparation and application | |
| IT1311584B1 (it) | Metodo per la realizzazione di calzature, e calzature ottenute contale metodo. | |
| IT1318986B1 (it) | Procedimento per la preparazione di (s)-n-terbutil-1,2,3,4-tetraidroisochinolin-3-carbossiammide. |